Advances in prostate cancer detection may lower deaths, according to Yale study
Dr. Nicholas Brutus, urology resident and lead author at the Yale School of Medicine, says cancer deaths may decrease because of major advances in technology for diagnosing and treating prostate cancer.
More Stories
Experts say prostate cancer remains a leading cause of cancer deaths in men. But new research at Yale shows that is likely to change.
Dr. Nicholas Brutus, urology resident and lead author at the Yale School of Medicine, says cancer deaths may decrease because of major advances in technology for diagnosing and treating prostate cancer.
Brutus says men 40 and older should get screened. You're at higher risk if a family member has had prostate cancer. Some symptoms include frequent urination, pain or discomfort in the lower pelvic area, and blood in the urine or semen. A simple blood test can detect it.
"Because we've seen many advances with technologies for screening, different treatment modalities, as well as even things like social media and the use of artificial intelligence to make talking about prostate cancer and men's health more comfortable for the average man," said Brutus.
If doctors suspect prostate cancer, the next step is typically imaging, and in some cases, removal of the prostate. Ninety-nine percent of men diagnosed before the cancer spreads live for at least five years, with many being cured.
